About EnZeta Immunotherapies
EnZeta Immunotherapies is a private company based in Coral Gables, Florida, incorporated in 2023 in Delaware. It has reported $855,000 raised in three offerings on Form D since September 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2025 | Feb 20, 2025amended Mar 6, 2026 | $840,000of $2.3M target | 10 | $84,000 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 14, 2023 | Sep 29, 2023 | $5,000fully sold | 5 | $1,000 | EquityRule 506(b) | Form D ↗ |
| Sep 8, 2023 | Sep 26, 2023 | $10,000fully sold | 2 | $5,000 | Convertible NoteRule 506(b) | Form D ↗ |
| Total, three offerings | $855,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EnZeta Immunotherapies's Form D filed Mar 6, 2026.
PK
Paul Kelly
President and director
ST